Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis

被引:31
|
作者
Wang, Wei [1 ]
Yang, Ni [1 ]
Wen, Ri [1 ]
Liu, Chun-Feng [1 ]
Zhang, Tie-Ning [1 ]
机构
[1] China Med Univ, Dept Pediat, Shengjing Hosp, Shenyang, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
lncRNA; sepsis; biomarker; inflammation; cardiovascular dysfunction; acute lung injury; acute kidney injury; ACUTE KIDNEY INJURY; CAMPAIGN INTERNATIONAL GUIDELINES; INDUCED CARDIAC INFLAMMATION; COMPETITIVE ENDOGENOUS RNA; INDUCED BRAIN-INJURY; C-REACTIVE PROTEIN; LPS-INDUCED SEPSIS; MESSENGER-RNA; LNCRNA MALAT1; SEPTIC SHOCK;
D O I
10.3389/fcimb.2021.563126
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection and is characterized by a hyperinflammatory state accompanied by immunosuppression. Long noncoding RNAs (lncRNAs) are noncoding RNAs longer than 200 nucleotides and have important roles in mediating various biological processes. Recently, lncRNAs were found to exert both promotive and inhibitory immune functions in sepsis, thus participating in sepsis regulation. Additionally, several studies have revealed that lncRNAs are involved in sepsis-induced organ dysfunctions, including cardiovascular dysfunction, acute lung injury, and acute kidney injury. Considering the lack of effective biomarkers for early identification and specific treatment for sepsis, lncRNAs may be promising biomarkers and even targets for sepsis therapies. This review systematically highlights the recent advances regarding the roles of lncRNAs in sepsis and sheds light on their use as potential biomarkers and treatment targets for sepsis.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Long noncoding RNAs: A potential target in sepsis-induced cellular disorder
    Lu, Furong
    Hong, Yuan
    Liu, Lizhen
    Wei, Ning
    Lin, Yao
    He, Junbing
    Shao, Yiming
    EXPERIMENTAL CELL RESEARCH, 2021, 406 (02)
  • [2] Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis
    Wang, Chuqiao
    Liang, Guorui
    Shen, Jieni
    Kong, Haifan
    Wu, Donghong
    Huang, Jinxiang
    Li, Xuefeng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] REGULATORY ROLE OF NONCODING RNA IN SEPSIS AND SEPSIS-ASSOCIATED ORGAN DYSFUNCTION: AN UPDATED SYSTEMATIC REVIEW
    Zhang, Tao
    Yang, Yu-Hang
    Liu, Yong-Ping
    Zhang, Tie-Ning
    Yang, Ni
    SHOCK, 2022, 58 (05): : 434 - 456
  • [4] N6-methyladenosine modification: Regulatory mechanisms and therapeutic potential in sepsis
    Wang, Wei
    Wang, Huaili
    Sun, Tongwen
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [5] The role and therapeutic potential of SIRTs in sepsis
    You, Jiaqi
    Li, Yilin
    Chong, Wei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [6] RNA regulatory networks in animals and plants: a long noncoding RNA perspective
    Bai, Youhuang
    Dai, Xiaozhuan
    Harrison, Andrew P.
    Chen, Ming
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2015, 14 (02) : 91 - 101
  • [7] Long noncoding RNA: a new contributor and potential therapeutic target in fibrosis
    Jiang, Xiaoying
    Zhang, Fujun
    EPIGENOMICS, 2017, 9 (09) : 1233 - 1241
  • [8] Potential Roles of Long Noncoding RNAs as Therapeutic Targets in Renal Fibrosis
    Jung, Hyun Jin
    Kim, Hyun-Ju
    Park, Kwan-Kyu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [9] Non-coding RNA: a potential biomarker and therapeutic target for sepsis
    Zhang, Tie-Ning
    Li, Da
    Xia, Jing
    Wu, Qi-Jun
    Wen, Ri
    Yang, Ni
    Liu, Chun-Feng
    ONCOTARGET, 2017, 8 (53) : 91765 - 91778
  • [10] Mechanisms of Long Noncoding RNA Nuclear Retention
    Guo, Chun-Jie
    Xu, Guang
    Chen, Ling-Ling
    TRENDS IN BIOCHEMICAL SCIENCES, 2020, 45 (11) : 947 - 960